FDA Awards DRT Strategies New IT Modernization and Project & Program Management Contracts Totaling $6.2M

DRT Strategies further expands its government health IT practice with new technology contracts at FDA’s Office of New Drugs (OND) and Center for Drug Evaluation and Research (CDER).

Arlington, VA – September 17, 2018 – DRT Strategies, Inc. (DRT) (http://www.drtstrategies.com), a leading management and technology firm, announced today that the Food and Drug Administration (FDA) has awarded the company new contracts with FDA’s Office of New Drugs (OND) for information technology (IT) project and program management, scientific writing, medical editing, and logistical support to modernize IT systems used to improve FDA’s drug review process. The total value of the multiple contract awards is $6.2 million over twelve months.

Specifically, the new contracts tap DRT’s expertise to guide the Center for Drug Evaluation and Research (CDER) toward fulfilling its 21st Century Cures Act objectives to use technology to achieve faster and higher quality reviews of new drugs developed by the pharmaceutical industry.

“These new contract awards are hard-earned by DRT’s talented Health IT team and their focus on exceeding customer expectations.”

Kathy Taylor, Vice President, Health Business Unit at DRT Strategies.

“For close to a decade and with demonstrated success, we have provided a wide array of technology services and management support to the FDA. We are proud to support the FDA’s contributions to America’s public health, and grateful for the opportunity to expand our work within the FDA, CDER, and OND.”

About FDA OND

The Office of New Drugs (OND) ensures that safe and effective drugs and biologics are available to the American people. OND is comprised of 6 offices with 19 review divisions. Its role is twofold: review applications and make an approval decision; and set guidance and policy to ensure an efficient review process. OND reviews drug applications, interacts with the pharmaceutical industry and ultimately decides whether the benefits of a drug outweigh the known risks.

About DRT Strategies

DRT Strategies, Inc. (DRT) is a leading management and technology firm providing information technology (IT) solutions, health IT services, program management and financial management solutions to federal agencies and enterprise clients in the technology and financial services sectors. The company is an Amazon Web Services (AWS) Consulting Partner, holds an ISO 9001 certification and has achieved CMMI-DEV Level 3.  DRT is headquartered in Arlington, Virginia, with offices in Washington, D.C., Baltimore, Maryland, Atlanta, Georgia, and Kansas City, Missouri. More information on the company can be found at www.drtstrategies.com.